2m 2m 2m 2m 2m 2m 2m
Innoviva (INVA)
NASDAQ
$21.70+$0.34 (+1.62%)
Price as of Jun 03, 2026 5:18 PM EDT- $1.6BMarket Cap
- 3.64%1-Year Change
- BiotechnologyIndustry
Innoviva (INVA)
$21.70+$0.34 (+1.62%)
INVA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.35 | ||
Change | -$0.16 (-0.74%) | ||
Open | $21.50 | ||
High | $21.71 | ||
Low | $21.28 | ||
Previous Close | $21.51 | ||
Volume | 1,047,117 | ||
30-Day Average Volume | 886,074 | ||
1-Week Change | -5.86% | ||
1-Month Change | -7.62% | ||
1-Year Change | 3.64% | ||
3-Year Change | 62.11% | ||
5-Year Change | 60.41% | ||
Fundamentals | |||
Shares Outstanding | 73.8M | ||
Total Assets | $1.8B | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | $55.2M | ||
Net Income | $186.6M | ||
Free Cash Flow | $34.8M | ||
EBIT | $240.0M | ||
EBITDA | $246.6M | ||
Net Working Capital | $736.1M | ||
EPS | $2.22 | ||
Enterprise Value/EBITDA | 5 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 1 | ||
P/E | 10 | ||
PEG | 0 | ||
Price/Free Cash Flow | 45 | ||
Price/Operating Cash Flow | 45 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 09/08/2015 | ||
Last Split Factor | 1 : 100 | ||
Last Split Date | 06/17/2013 | ||
Earnings & Revenue